clinical trial · NCT06966401
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive DisorderNBI-1065845
brief summary
This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.
started
Apr 16, 2025
primary completion
May 1, 2029
completion
May 1, 2030
last updated
Apr 23, 2026
official title
A Long-Term, Open-Label Study to Assess the Safety and Tolerability of NBI-1065845 as Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol